Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
A web-based electronic neurology referral system: a solution for an overburdened healthcare system?
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
Pediatric optic neuritis.
Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS).
Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.
Antibodies to potassium channels in multiple sclerosis.
Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress.
Interferon Beta and Glatiramer Acetate Therapy.
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation.
Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.
Neutralizing Nanobodies targeting diverse chemokines effectively inhibit chemokine function.
Identification of suitable reference genes for peripheral blood mononuclear cell subset studies in multiple sclerosis.
The effects of aquatic therapy on mobility of individuals with neurological diseases: A systematic review.
Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study.
Robot-assisted vs. sensory integration training in treating gait and balance dysfunctions in patients with multiple sclerosis: a randomized controlled trial.
Multiple sclerosis susceptibility alleles in African Americans.
Reported outcomes after the endovascular treatment of chronic cerebrospinal venous insufficiency.
Jekyll and Hide: The two faces of amyloid β.
Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis.
Pulmonary Hypertension and Multiple Sclerosis - Coincidence or Association?
Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
The role of complement in neurological and neuropsychiatric diseases.
Pages
« first
‹ previous
…
262
263
264
265
266
267
268
269
270
…
next ›
last »